| Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐and lenalidomide‐containing regimens. NPF Storrar, A Mathur, PRE Johnson, PH Roddie British journal of haematology 185 (1), 2019 | 49 | 2019 |
| Electronic cigarettes: a brief update A Mathur, OJ Dempsey Journal of the Royal College of Physicians of Edinburgh 48 (4), 346-351, 2018 | 35 | 2018 |
| Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression-and Epstein-Barr virus-associated lymphoproliferative disease S Kazi, A Mathur, G Wilkie, K Cheal, R Battle, N McGowan, N Fraser, ... Haematologica 104 (8), e356, 2019 | 23 | 2019 |
| Investigating thrombocytosis A Mathur, S Samaranayake, NPF Storrar, MA Vickers BMJ 366, 2019 | 18 | 2019 |
| Intrapulmonary autoantibodies to HSP72 are associated with improved outcomes in IPF R Mills, A Mathur, LM Nicol, JJ Walker, AA Przybylski, AC Mackinnon, ... Journal of Immunology Research 2019, 2019 | 11 | 2019 |
| Improving intravenous fluid prescribing A Mathur, G Johnston, L Clark Journal of the Royal College of Physicians of Edinburgh 50 (2), 181-187, 2020 | 10 | 2020 |
| The management of chronic cough A Mathur, PSK Liu-Shiu-Cheong, GP Currie QJM: An International Journal of Medicine 112 (9), 651-656, 2019 | 10 | 2019 |
| Replacing procarbazine with dacarbazine in escalated BEACOPP dramatically reduces the post treatment haematopoietic stem and progenitor cell mutational burden in Hodgkin … A Santarsieri, E Mitchell, K Sturgess, P Brice, TF Menne, W Osborne, ... Blood 140 (Supplement 1), 1761-1764, 2022 | 6 | 2022 |
| Hyposplenism and gastrointestinal diseases: significance and mechanisms A Mathur, MH McLean, H Cao, MA Vickers Digestive Diseases 40 (3), 290-298, 2022 | 6 | 2022 |
| Chronic cough: a practical approach to assessment and management A Mathur, PSK Liu-Shiu-Cheong, A Munro, GP Currie Drug and Therapeutics Bulletin 57 (5), 74-79, 2019 | 4 | 2019 |
| Pulmonary sarcoidosis: a clinical update MK Hu, A Mathur, OJ Dempsey Journal of the Royal College of Physicians of Edinburgh 50 (3), 322-329, 2020 | 2 | 2020 |
| Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide A Mathur, J Edman, L Liang, NW Scott, HG Watson EJHaem 3 (4), 1305-1309, 2022 | 1 | 2022 |
| P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity A Santarsieri, K Sturgess, P Brice, TF Menne, W Osborne, T Creasey, ... HemaSphere 6, 7-8, 2022 | 1 | 2022 |
| Measurement of erythrocyte membrane mannoses to assess splenic function H Cao, A Mathur, C Robertson, A Antonopoulos, S Henderson, LP Girard, ... British Journal of Haematology 198 (1), 155-164, 2022 | 1 | 2022 |
| S18 A working definition and natural history of ‘minimal’ild RR Browne, A Mathur, A Marshal, PA McFarlane, GA Stewart, J Sharkey, ... Thorax 71 (Suppl 3), A12-A13, 2016 | 1 | 2016 |
| A bilateral stethoscope JA Walker, AK Mathur Anaesthesia 38 (2), 164-164, 1983 | 1 | 1983 |
| Are trichloroethylene vaporisers accurate? A comparison with halothane and enpurane vaporisers DG Rees, JA Walker, AK Mathur Anaesthesia 36 (11), 1060-1060, 1981 | 1 | 1981 |
| Anticoagulation in venous thromboembolism for the general physician K Stark, A Mathur, MM Khan Journal of the Royal College of Physicians of Edinburgh 54 (1), 74-83, 2024 | | 2024 |
| Drug-induced secondary haemophagocytic lymphohistiocytosis in hairy cell leukaemia K Stark, C Rowe, A Mathur, J Matossian, A Lawrie Journal of the Royal College of Physicians of Edinburgh 54 (1), 29-33, 2024 | | 2024 |
| Replacing procarbazine with dacarbazine in escalated BEACOPP reduces clinical toxicity with no loss of efficacy yet protects stem cells from excess somatic mutational damage A Santarsieri, E Mitchell, R Sanghvi, H Lee‐Six, K Sturgess, P Brice, ... Hematological Oncology 41, 356-357, 2023 | | 2023 |
